loader
Page is loading...
Print Logo Logo
Stethescope


SPEAKERS

Tarah Ballinger

Dr. Tarah Ballinger

Assistant Professor of Clinical Medicine
Indiana University School of Medicine
Dr. Christina Clarke Dur

Dr. Christina Clarke Dur

Head of Epidemiology, Senior Director of Medical Affairs
GRAIL
Bryan Hannon

Bryan Hannon

Regional Government Relations Director
American Cancer Society, Illinois Division
Kristin Jones

Kristin Jones

President and CEO
Indiana Health Industry Forum



SPEAKERS

Tarah Ballinger

Dr. Tarah Ballinger

Assistant Professor of Clinical Medicine
Indiana University School of Medicine
Dr. Christina Clarke Dur

Dr. Christina Clarke Dur

Head of Epidemiology, Senior Director of Medical Affairs
GRAIL
Bryan Hannon

Bryan Hannon

Regional Government Relations Director
American Cancer Society, Illinois Division
Kristin Jones

Kristin Jones

President and CEO
Indiana Health Industry Forum

As a result of the pandemic, 2020 saw a large drop-off in the screening rates for many types of cancer. In general, cancer is easier to treat when identified in early stages and “missed” cancers may be larger or more advanced when ultimately detected. While the impact of the pandemic on overall cancer deaths will not be clear for many years, it has produced both reasons for concern and optimism.

Please join us as our panel discusses the impact of COVID-19 on cancer screenings, whether the trend is reversing, and how innovation – particularly around multi-cancer early detection – may help current and future patients.

Questions? Email Lindsay Hulliberger or call 312-214-5661.

Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.